Mark Baum - Director, Eton Pharmaceuticals, Inc

As of March 16, 2020


Mark Baum Net Worth

  • Net worth is estimated to be at least $5.56M
  • Owns at least 794,745 units of Eton Pharmaceuticals, Inc stock

Mark Baum Trading

  • Largest purchase of shares was 10,000 units , worth over $60K on November 15, 2018
  • In total has made about 3 transactions over 2 years
  • Usually trades in March, with the busiest year in 2018, 2019 and 2020
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Mark Baum Mailing Address

  • Mailing address is C/o Imprimis Pharmaceuticals, Inc 12264 el Camino Real, Suite 350 San Diego CA 92130 CA

Eton Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Other Earnings Plans or Compensations
Stock Awards
Option Awards
Other Compensation
Total
Sean E. Brynjelsen 2020 $475,833 $218,700 - $1,305,360 $11,400 $2,011,293
Sean E. Brynjelsen 2019 $409,958 $186,500 - $1,338,750 $11,200 $1,946,408
W. Wilson Troutman 2020 $277,083 $108,000 - $509,629 $11,400 $906,112
W. Wilson Troutman 2019 $242,667 $87,500 - $523,260 $11,200 $864,627
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1710340/000149315221009679/formdef14a.htm

Eton Pharmaceuticals, Inc Insider Trading

  • The most recent transaction was 25,000 units sold on November 19, 2021 by Opaleye Management Inc worth over $116.71K
  • In the last 3 years, insiders at Eton Pharmaceuticals, Inc sold an estimated value of $20.77M and bought an estimated value of $3.27M
  • The most active traders are Opaleye Management Inc,  Sean Brynjelsen, President & CEO,  and Charles Casamento, Director
  • Insider trading is most common in March, with the busiest year in 2021

Eton Pharmaceuticals, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1